相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting inhibition of microtubule affinity regulating kinase 4 by Harmaline: Strategy to combat Alzheimer's disease
Mohd Adnan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2023)
Myricetin inhibits breast and lung cancer cells proliferation via inhibiting MARK4
Saleha Anwar et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2022)
Plumbagin Alleviates Intracerebroventricular-Quinolinic Acid Induced Depression-like Behavior and Memory Deficits in Wistar Rats
Mandeep Kumar Arora et al.
MOLECULES (2022)
Dietary Polyphenols as Therapeutic Intervention for Alzheimer's Disease: A Mechanistic Insight
Syed Nasir Abbas Bukhari
ANTIOXIDANTS (2022)
Focusing on the recent progress of tea polyphenol chemistry and perspectives
Shiming Li et al.
FOOD SCIENCE AND HUMAN WELLNESS (2022)
The emerging role of dark berry polyphenols in human health and nutrition
Jerome Higbee et al.
FOOD FRONTIERS (2022)
Polyphenols in Metabolic Diseases
Amin Gasmi et al.
MOLECULES (2022)
Polyphenols as Plant-Based Nutraceuticals: Health Effects, Encapsulation, Nano-Delivery, and Application
Zhiheng Zhang et al.
FOODS (2022)
Inhibition of MK2 kinase as a potential therapeutic target to control neuroinflammation in Alzheimer's disease
Shriyansh Srivastava et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2021)
Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases
Saleha Anwar et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2021)
Targeting Tau Hyperphosphorylation via Kinase Inhibition: Strategy to Address Alzheimer's Disease
Ahmad Abu Turab Naqvi et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases
Nur Shafika Mohd Sairazi et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
Ana Rakita et al.
SCIENTIFIC REPORTS (2020)
Glycogen synthase kinase-3 signaling in Alzheimer's disease
Elisabetta Lauretti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer's Disease Therapy
Anas Shamsi et al.
BIOMOLECULES (2020)
Discovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer Therapy
Saleha Anwar et al.
BIOMEDICINES (2020)
Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases
Saleha Anwar et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
MARK4 (Microtubule Affinity-Regulating Kinase 4)-Dependent Inflammasome Activation Promotes Atherosclerosis-Brief Report
Marc Clement et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Molecular interaction studies on ellagic acid for its anticancer potential targeting pyruvate dehydrogenase kinase 3
Rashmi Dahiya et al.
RSC ADVANCES (2019)
Plumbagin ameliorates memory dysfunction in streptozotocin induced Alzheimer's disease via activation of Nrf2/ARE pathway and inhibition of β-secretase
Kartik T. Nakhate et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance
Kalyana C. Nandipati et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
Recent Progress in Alzheimer's Disease Research, Part 2: Genetics and Epidemiology
Morgan Robinson et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita et al.
SCIENTIFIC REPORTS (2017)
MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells
Emad Heidary Arash et al.
EMBO REPORTS (2017)
Tau and neurodegenerative disease: the story so far
Khalid Iqbal et al.
NATURE REVIEWS NEUROLOGY (2016)
miR-515-5p controls cancer cell migration through MARK4 regulation
Olivier E. Pardo et al.
EMBO REPORTS (2016)
Ubiquitin-associated domain of MARK4 provides stability at physiological pH
Farha Naz et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2016)
A Guide to Transient Expression of Membrane Proteins in HEK-293 Cells for Functional Characterization
Amanda Ooi et al.
FRONTIERS IN PHYSIOLOGY (2016)
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Valentina Cappello et al.
SCIENTIFIC REPORTS (2016)
Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition
Farha Naz et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2015)
Optimization of culture medium for cell growth and expression of 648 antigen from Leishmania infantum chagasi in recombinant Escherichia coli M15
Michelle Rossana Ferreira Vaz et al.
ANNALS OF MICROBIOLOGY (2015)
Phenotypic Characterization of the Binding of Tetracycline to Human Serum Albumin
Zhenxing Chi et al.
BIOMACROMOLECULES (2011)
Plumbagin Inhibits Proliferative and Inflammatory Responses of T Cells Independent of ROS Generation But by Modulating Intracellular Thiols
Rahul Checker et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia
Tae Gen Son et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Plumbagin, Isolated from Plumbago zeylanica, Induces Cell Death through Apoptosis in Human Pancreatic Cancer Cells
Chien-An Chen et al.
PANCREATOLOGY (2009)
Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins
Larissa A. Munishkina et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Protein kinase inhibitors: Insights into drug design from structure
MEM Noble et al.
SCIENCE (2004)
MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes
B Trinczek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antioxidant properties of Plumbago zeylanica, an Indian medicinal plant and its active ingredient, plumbagin
JC Tilak et al.
REDOX REPORT (2004)
Protein kinases - the major drug targets of the twenty-first century?
P Cohen
NATURE REVIEWS DRUG DISCOVERY (2002)
Mechanisms of tryptophan fluorescence shifts in proteins
JT Vivian et al.
BIOPHYSICAL JOURNAL (2001)
分享论文
